Journal article
Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells
The Journal of immunology (1950), Vol.201(10), pp.2910-2922
11/15/2018
DOI: 10.4049/jimmunol.1700638
PMCID: PMC6219912
PMID: 30291167
Abstract
Helminths stimulate the secretion of Th2 cytokines, like IL-4, and suppress lethal graft-versus-host disease (GVHD) after bone marrow transplantation. This suppression depends on the production of immune-modulatory TGF-β and is associated with TGF-β-dependent in vivo expansion of Foxp3
regulatory T cells (Treg). In vivo expansion of Tregs is under investigation for its potential as a therapy for GVHD. Nonetheless, the mechanism of induced and TGF-β-dependent in vivo expansion of Tregs, in a Th2 polarized environment after helminth infection, is unknown. In this study, we show that helminth-induced IL-4 production by host cells is critical to the induction and maintenance of TGF-β secretion, TGF-β-dependent expansion of Foxp3
Tregs, and the suppression of GVHD. In mice with GVHD, the expanding donor Tregs express the Th2-driving transcription factor, GATA3, which is required for helminth-induced production of IL-4 and TGF-β. In contrast, TGF-β is not necessary for GATA3 expression by Foxp3
Tregs or by Foxp3
CD4 T cells. Various cell types of innate or adaptive immune compartments produce high quantities of IL-4 after helminth infection. As a result, IL-4-mediated suppression of GVHD does not require invariant NKT cells of the host, a cell type known to produce IL-4 and suppress GVHD in other models. Thus, TGF-β generation, in a manner dependent on IL-4 secretion by host cells and GATA3 expression, constitutes a critical effector arm of helminthic immune modulation that promotes the in vivo expansion of Tregs and suppresses GVHD.
Details
- Title: Subtitle
- Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells
- Creators
- Xiaoqun Guan - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Yue Li - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Ahmed Metwali - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242George J Weiner - Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Weiren Liu - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Nicholas Zavazava - Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Hung-Lin Chen - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242David E Elliott - Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Jamie Truscott - Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242M Nedim Ince - Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Sonay Beyatli - Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242Richard S Blumberg - Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115Joseph F Urban Jr - Diet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705; andBruce R Blazar - Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.201(10), pp.2910-2922
- DOI
- 10.4049/jimmunol.1700638
- PMID
- 30291167
- PMCID
- PMC6219912
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Grant note
- R01 AI034495 / NIAID NIH HHS P30 ES005605 / NIEHS NIH HHS R56 AI116715 / NIAID NIH HHS R01 HL095791 / NHLBI NIH HHS I01 BX002906 / BLRD VA R01 HL118979 / NHLBI NIH HHS I01 BX002715 / BLRD VA U19 AI051731 / NIAID NIH HHS P30 CA086862 / NCI NIH HHS R37 AI034495 / NIAID NIH HHS R37 HL056067 / NHLBI NIH HHS R01 DK044319 / NIDDK NIH HHS R01 HL056067 / NHLBI NIH HHS
- Language
- English
- Date published
- 11/15/2018
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Hematology, Oncology, and Blood & Marrow Transplantation; Gastroenterology and Hepatology; Pharmaceutical Sciences and Experimental Therapeutics; Radiation Oncology; Internal Medicine
- Record Identifier
- 9984094535802771
Metrics
41 Record Views